1994 CE
Zidovudine guidance to reduce perinatal HIV transmission
Epidemics & public health · VIH/sida · Salud maternoinfantil · Prevención
The 1994 public-health recommendations incorporated ACTG 076 results on zidovudine for selected pregnant people and newborns to reduce the risk of perinatal HIV transmission. The result concerned a specific regimen and trial population; its adoption required diagnosis, prenatal care, consent, and access that were not universal.
Precision, calendar, and review
- Start
- year · no uncertainty qualifier in this record
- Calendar and convention
- Historical-era years; the source calendar is not identified. No conversion of days is assumed.
- Year zero
- The scale goes from 1 BCE to 1 CE without year zero. Changing era names changes labels only.
- Documentary review
- Date not recorded
Reading the date: point event.
Sources
- clinicalinfo.hiv-stage.od.nih.gov (opens in a new tab)
Source provenance and scope
- Publication date
- Pending verification: the source could not be accessed
- Bibliographic date checked
- 2026-09-23
The correspondence between this reference and individual claims has not yet been itemized.
This record is an editorial synthesis. Consult the sources to check claims and their limits. Chronological relationships alone do not establish causation.